Antinociceptive, hypothermic, and appetitive effects of vaped and injected Δ9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex

Advances in drug vapor exposure systems utilizing e-cigarette technology have enabled evaluation of Δ-9-tetrahydrocannabinol (THC) vapor effects in laboratory animals. The purpose of this study was to 1) establish a range of parameters of THC vapor exposure in rats sufficient to produce a behavioral dose-effect curve in a battery of tasks sensitive to THC; 2) to investigate sex differences in the effects of THC vapor exposure and THC injection (intraperitoneal, IP) on these behaviors in two strains of outbred rats. Male and female Wistar and Sprague Dawley rats (N=22, 5-6/group) received THC via IP injection (1-20 mg/kg) and passive exposure to THC vapor (200 mg/ml; 5 conditions) in a within subject design. The effects of vaped and injected THC were determined using the tail-withdrawal assay for nociception, rectal measurements of body temperature, and progressive-ratio responding for food pellets. Plasma THC concentrations were assessed after 10 mg/kg IP THC or THC vapor. THC produced dose and exposure-dependent antinociception and hypothermia. THC vapor produced inverted U-shaped effects in motivation to obtain food, while IP THC reduced PR breakpoints. Plasma THC concentrations were higher after 10 mg/kg IP THC (152 ng/mL) compared to the highest vapor exposure condition tested (38 ng/mL). THC vapor exposure produces reliable, dose-orderly effects on nociception, body temperature, and food-maintained behavior that is comparable to effects observed after IP THC. There are considerable differences between the time course of behavioral outcomes produced by these two different routes of administration.

[1]  E. Weerts,et al.  Translational models of cannabinoid vapor exposure in laboratory animals , 2020, Behavioural pharmacology.

[2]  R. Njai,et al.  Modes of marijuana use - smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States. , 2020, Drug and alcohol dependence.

[3]  D. Hammond,et al.  Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. , 2020, The International journal on drug policy.

[4]  Matthew W Buczynski,et al.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems , 2020, Journal of Neuroscience Methods.

[5]  R. McLaughlin,et al.  Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats , 2019, The Journal of Neuroscience.

[6]  T. Kerr,et al.  Lasting effects of repeated ∆9‐tetrahydrocannabinol vapour inhalation during adolescence in male and female rats , 2019, British journal of pharmacology.

[7]  Jon F. Davis,et al.  Vapor Cannabis Exposure Promotes Genetic Plasticity in the Rat Hypothalamus , 2019, Scientific Reports.

[8]  Kristy L Marynak,et al.  Substances used in electronic vapor products among adults in the United States, 2017 , 2019, Addictive behaviors reports.

[9]  B. Clowers,et al.  Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats. , 2019, Experimental and clinical psychopharmacology.

[10]  K. Janda,et al.  Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions , 2017, Neuropharmacology.

[11]  M. Cole,et al.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats , 2018, Pharmacology Biochemistry and Behavior.

[12]  P. Piazza,et al.  Cannabinoid‐Induced Tetrad in Mice , 2017, Current protocols in neuroscience.

[13]  M. Cole,et al.  Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats , 2017, bioRxiv.

[14]  L. Parsons,et al.  Inhaled delivery of Δ9-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology , 2016, Neuropharmacology.

[15]  D. Pardini,et al.  Prevalence and correlates of vaping cannabis in a sample of young adults. , 2016, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[16]  B. Favrat,et al.  Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? , 2016, Scientific Reports.

[17]  Dustin C. Lee,et al.  Online survey characterizing vaporizer use among cannabis users. , 2016, Drug and alcohol dependence.

[18]  Dustin C. Lee,et al.  Vaping cannabis (marijuana): parallel concerns to e-cigs? , 2015, Addiction.

[19]  D. Camenga,et al.  Pediatrics Digest , 2015, Pediatrics.

[20]  B. Favrat,et al.  Int. J. Environ. Res. Public Health , 2015 .

[21]  L. Parsons,et al.  Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats , 2015, Psychopharmacology.

[22]  M. Taffe,et al.  Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in Sprague‐Dawley rats , 2015, British journal of pharmacology.

[23]  C. Bradshaw,et al.  Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ9-tetrahydrocannabinol (THC) , 2015, Behavioural Processes.

[24]  Danielle E. Ramo,et al.  Prevalence and correlates of electronic-cigarette use in young adults: findings from three studies over five years. , 2015, Addictive behaviors.

[25]  L. Manwell,et al.  A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents. , 2014, Journal of pharmacological and toxicological methods.

[26]  L. Manwell,et al.  A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents. , 2014, Journal of pharmacological and toxicological methods.

[27]  R. Witkamp,et al.  The endocannabinoid system and appetite: relevance for food reward , 2014, Nutrition Research Reviews.

[28]  C. Lacroix,et al.  Fast liquid chromatography/tandem mass spectrometry determination of cannabinoids in micro volume blood samples after dabsyl derivatization. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  S. Goldberg,et al.  Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems , 2005, Neuropsychopharmacology.

[30]  D. Barber,et al.  Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats , 2005, Behavioural pharmacology.

[31]  E. Berry,et al.  Tetrahydrocannabinol and endocannabinoids in feeding and appetite. , 2002, Pharmacology & therapeutics.

[32]  A. Lichtman,et al.  Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler. , 2002, Drug and alcohol dependence.

[33]  R. Craft,et al.  Sex differences in antinociceptive and motoric effects of cannabinoids. , 2001, European journal of pharmacology.

[34]  J. Koch.  Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets , 2001, Pharmacology Biochemistry and Behavior.

[35]  J. Koch.  Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. , 2001, Pharmacology, biochemistry, and behavior.

[36]  A. Lichtman,et al.  Pharmacological evaluation of aerosolized cannabinoids in mice. , 2000, European journal of pharmacology.

[37]  N. R. Richardson,et al.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy , 1996, Journal of Neuroscience Methods.

[38]  K. Rice,et al.  Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. , 1993, The Journal of pharmacology and experimental therapeutics.